Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Hydrothorax; Pneumothorax; Hydro-pneumothorax;
مقالات ISI مزوتلیوما پلورال بدخیم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مزوتلیوما پلورال بدخیم; AE; asbestos exposure; CT; computed tomography; LC; lung cancer; LDCT; low-dose computed tomography; MPM; malignant pleural mesothelioma; PQs; pleural plaques; SCLS/DOTS; subpleural curvilinear shadow/subpleural dots; Asbestos; Low-dose CT; Screening; Lun
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Radiotherapy; Prophylactic; Procedure tract;
Keywords: مزوتلیوما پلورال بدخیم; BSE; backscattered electrons; BSED; back-scattered electron detector; GI; gastrointestinal; gwt; gram of wet tissue; IARC; International Agency for Research on Cancer; MFs; microscopic fields; MPM; malignant pleural mesothelioma; NIOSH; National Institute
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Oncology therapeutics; Biomarkers; Immunotherapy; Chemotherapy;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Thoracic cavity segmentation; Mesothelioma texture analysis; Photodynamic therapy; Computed tomography;
Keywords: مزوتلیوما پلورال بدخیم; malignant pleural mesothelioma; PD-L1; gene expression profile; NanoString technology;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Pathological response; Prognosis; Survival; Extrapleural pneumonectomy;
Keywords: مزوتلیوما پلورال بدخیم; BSC; best supportive care; EORTC; European Organisation for Research and Treatment of Cancer; EPP; extrapleural pneumonectomy; IMIG; International Mesothelioma Interest Group; MPM; malignant pleural mesothelioma; PEM; pemetrexed; PD; pleurectomy decortica
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Pleural cavity irradiation; Pleurectomy/decortication; Tomotherapy;
Keywords: مزوتلیوما پلورال بدخیم; Asbestos; Centralized care model; Evidence-based treatment; Guidelines based practice; Malignant pleural mesothelioma; Phone triage; Single-payer system; Veterans; Veterans Administration Healthcare System;
Keywords: مزوتلیوما پلورال بدخیم; Fluoro-edenite; Fibulin-3; Lung; Fibroblasts; Asbestos; Biancavilla; Malignant pleural mesothelioma; Cancer;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Pleurectomy/decortication; Accelerated hypofractionated radiotherapy; Helical tomotherapy; Mésothéliome pleural malin; Pleurectomie/décortication; Radiothérapie hypofractionnée accélérée; Tomothérapie hélicoïdale
Keywords: مزوتلیوما پلورال بدخیم; AE; adverse event; CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; EGFR; epidermal growth factor receptor; FAK; focal adhesion kinase; IGFR; insulin growth factor receptor; MPM; malignant pleural mesothelioma; MTD; maximum tolerated dose; mTOR; mamma
Keywords: مزوتلیوما پلورال بدخیم; Controlling nutritional status; Immune-nutritional index; Malignant pleural mesothelioma; Malnutrition; Prognosis;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Intensity-modulated pleural radiation therapy; IMPRINT; Conventional RT; Pleurectomy/decortication;
Keywords: مزوتلیوما پلورال بدخیم; Malignant Pleural Mesothelioma; Early stage; Pleurectomy and decortication; Hyperthermic TntraTHOracic Chemotherapy;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Pneumothorax; Tumors in children; SEER analysis
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Pathology reporting; Immunohistochemistry; Diagnosis; Cancer registry;
Keywords: مزوتلیوما پلورال بدخیم; Malignant Pleural Mesothelioma; Recommendations; Epidemiology; Diagnosis; Therapy; Supportive care; End of life;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Spontaneous remission; Tumour regression; Herbal products; Immune response
Keywords: مزوتلیوما پلورال بدخیم; Dlco; diffusing capacity of the lung for carbon monoxide; EORTC QLQ-C30; European Organization for Research and Treatment of Cancer Core Quality of Life Questionaire-C30; EPD; extended pleurectomy and decortication; EPP; extrapleural pneumonectomy; FEV1;
Keywords: مزوتلیوما پلورال بدخیم; Asbestos; Lymphocyte-to-monocyte ratio; Malignant pleural mesothelioma; Prognostic score;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Biomarkers; Malignant pleural effusion; ThoracoscopyMesotelioma pleural maligno; Biomarcadores; Derrame pleural maligno; Toracoscopia
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Epidemiology; Chemotherapy; Immunotherapy; Second line; Maintenance
Keywords: مزوتلیوما پلورال بدخیم; Extrapleural pneumonectomy; Induction chemotherapy; Selection score; Malignant pleural mesothelioma; Multimodality therapy
Keywords: مزوتلیوما پلورال بدخیم; Polymeric nanoparticle; Epigenetic inhibitor; Drug delivery; Controlled release; Stimuli-responsive; ADCA; adenocarcinoma; BrD; bromodomain; BRET; bioluminescence resonance energy transfer; DDS; drug delivery system; DLS; dynamic light scattering; DMF; di
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Pemetrexed; Liposomes; Orthotopic tumor model; Intrapleural administration;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Genetic variation; Next-generation sequencing; Genetic characterization; BAP1 gene; NF2 gene; PI3K gene;
Keywords: مزوتلیوما پلورال بدخیم; α-TOS; α-tocopheryl succinate; BAP1; BRCA1 associated protein-1; BRCA1; breast cancer susceptibility gene 1; CDK4; cyclin-dependent kinase 4; CEA; carcinoembryonic antigen; CSC(s); cancer stem(-like) cell(s); CTGF; connective tissue growth factor (CCN2)
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Epithelioid histology; Sarcomatoid histology; Pleurectomy/decortication; Gingival metastasis;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Perineural spread; Spinal cord neoplasm; Intramedullary tumor; Magnetic resonance imaging;
Keywords: مزوتلیوما پلورال بدخیم; Osteopontin; Malignant pleural mesothelioma; Diagnostic accuracy; Systematic review; Meta-analysis;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Pleurectomy/decortication; Intensity modulated radiation therapy; IMRT; Tomotherapy; Pneumonitis;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Cisplatin; Gemcitabine; Pemetrexed; Chemotherapy;
Keywords: مزوتلیوما پلورال بدخیم; Fibulin-3; Malignant pleural mesothelioma
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Extrapleural pneumonectomy; Pleurectomy/decortication; Chemotherapy; Palliative treatment;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Radical surgery; Extrapleural pneumonectomy; Pleurectomy; VATS
Keywords: مزوتلیوما پلورال بدخیم; MicroRNAs; Malignant pleural mesothelioma; Pleural inflammation; Mesothelial hyperplasia; Tumorigenesis;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Phase 1; Response rate; Toxicity; Molecular pathways; Targeted therapy;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Neoadjuvant chemotherapy; Multimodality treatment;
Keywords: مزوتلیوما پلورال بدخیم; 10; 14; CT; computed tomography; HIOC; hyperthermic intraoperative cisplatin chemotherapy; MPM; malignant pleural mesothelioma;
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Italian recommendations; Epidemiology; Etiology; Diagnosis; Therapy;
A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Angiogenesis; ALK-1 antagonist; Systemic therapy;
Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Clinical trials; Clinicaltrials.gov; Radiotherapy; Surgery; Chemotherapy; Immunotherapy; Guidelines;
Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural Mesothelioma
Keywords: مزوتلیوما پلورال بدخیم; Malignant pleural mesothelioma; Microsatellite instability; Mismatch repair protein; Immunohistochemistry; PD-L1;
Effects of Reduction in Tumor Burden on Survival in Epithelioid Malignant Pleural Mesothelioma
Keywords: مزوتلیوما پلورال بدخیم; CR; complete response; FDA; Food and Drug Administration; HR; hazard ratio; MPM; malignant pleural mesothelioma; mRECIST; modified pleural Response Evaluation Criteria in Solid Tumors; ORR; objective response rate; OS; overall survival; PD; progression of
Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22
Keywords: مزوتلیوما پلورال بدخیم; CD26; Ubiquitin-specific protease 22; Malignant pleural mesothelioma; Humanized anti-CD26 monoclonal antibody; CD26si; siRNA against CD26; CSC; cancer stem cell; Csh; control shRNA; Csi; control siRNA; CDKI; cyclin-dependent kinase inhibitor; HuCD26mAb; h
Uptake-release by MSCs of a cationic platinum(II) complex active in vitro on human malignant cancer cell lines
Keywords: مزوتلیوما پلورال بدخیم; MPM; malignant pleural mesothelioma; GBM; glioblastoma multiforme; PAC; pancreatic adenocarcinoma; GCB; gemcitabine; CisPt; cisplatin; MSCs; mesenchymal stromal cells; caPt(II)-complex; cationic platinum(II) complex; CFPAC-1; pancreatic carcinoma cell lin
Hétérogénéité moléculaire des mésothéliomes pleuraux malins
Keywords: مزوتلیوما پلورال بدخیم; Cancer thoracique; Mésothéliome pleural malin; Altération moléculaire; Hétérogénéité tumorale; Génomique; Médecine de précision; Thoracic cancer; Malignant pleural mesothelioma; Molecular alteration; Tumor heterogeneity; Genomic; Precision med